CClinicalTrials.gg
Not yet recruitingNCT06697548Updated Nov 20, 2024

Conservative Care for Pelvic Pain (C2P2) in Women Service Members

An interventional study of Pain Neuroscience Education and Lumbopelvic and Hip Therapeutic Exercise in Chronic Pelvic Pain, sponsored by Baylor University. Not yet recruiting at 2 sites in United States. Open to female participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2024-11-20.

Sponsored by Baylor University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
Female
01

Study summary

This study will test the effectiveness of emerging conservative interventions for treatment of chronic pelvic pain (CPP) that can be performed without intravaginal specialization. Participants with CPP will be randomly assigned to one of three groups. The first group will receive treatment based on what they normally would receive, including medications, education, and exercise (Usual Care Group). The second group will receive contemporary non-vaginal treatment including manual therapy, dry needling, and specific breathing training (Emerging Field-expedient Care Group). The third group will receive intravaginal treatment by a pelvic health specialist (Gold-standard Intravaginal Specialist Care Group). Participants will be asked about their pain and symptoms and have measurements taken of their pelvic and back muscles after 1, 3, 6, and 12 months. In addition to seeing which treatments work best, clinical decision tools (using medical and trauma history along with clinical examination) will be developed to identify women with CPP likely to respond favorably to non-vaginal conservative interventions. This study will help determine the best non-vaginal treatment strategies for women with CPP and help clinicians quickly determine which patients are likely to benefit from treatment by non-pelvic health physical therapists (e.g., in theater), vs. patients who should be referred for pelvic health specialty care.

Read the detailed description

This trial will measure both clinical outcomes (pain, pelvic floor symptoms, work/duty absenteeism) and physiologic outcomes (pelvic floor and lumbopelvic muscle function and pain sensitivity) at 1 week and after 1, 3, 6, and 12 months of three different conservative physical therapy treatments. It is hypothesized that women who receive emerging field-expedient care will report greater improvements than those who receive only usual care, and their outcomes will be no worse than women who receive gold-standard intravaginal specialist care. Additionally, clinical decision tools incorporating characteristics from medical and trauma history, along with clinical examination, will be developed to identify women with CPP likely to respond favorably to emerging field-expedient care vs. requiring gold-standard intravaginal specialist care.

02

Conditions studied

  • Chronic Pelvic Pain

Browse trials for

Keywords

  • Pelvic health
  • Chronic pelvic pain
  • Physical therapy
  • Military
  • womens health
03

In context

Pelvic Pain

375 studies on the registry are indexed under Pelvic Pain; 83 are open to participants now.

This study's planned enrollment of 300 is above the median of 54 across 273 interventional studies indexed under Pelvic Pain.

Browse Pelvic Pain studies →

Lead sponsor

Baylor University is the lead sponsor of 40 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  1. Pain of at least 3 months duration in the abdominal-lumbopelvic area, defined as below the umbilicus, between the two ilia, and above the pubic symphysis including the vulvar, perineal, and vaginal regions.

Exclusion criteria

Exclusion Criteria:

  1. Sign that pelvic pain may be due to other serious medical issue (recent history of abdominal pelvic surgery, current infection, disrupted tissue integrity, neoplasm, or history of radiation to the pelvic floor tissue or the tissues being measured for stiffness).
  2. Chronic debilitating medical conditions (e.g., fibromyalgia, lupus, complex regional pain syndrome, multiple sclerosis or other progressive neurologic condition).
  3. Currently pregnant or pregnancy in the last 6 months.
  4. Body mass index over 33 (Waco participants only due to limitation of the instrumentation).
  5. Soldiers in an Advanced Individual Training (AIT) status.
  6. Previous intervention to address lumbopelvic muscle stiffness or pain such as dry needling, injections, or soft tissue intervention of any kind in the past 6 months.
  7. Inability to read English at an 8th grade reading level (any participant unable to read the informed consent form, which will be written at an 8th grade level).
  8. Inability to legally provide informed consent for any other reason.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
300 participants (estimated)

Study arms

  • Active comparator
    Usual Care

    Usual Care Group will receive their current medical management care along with study-specific patient education and progressive home exercise.

    Other: Lumbopelvic and Hip Therapeutic Exercise · Other: Chronic Pelvic Pain Education

  • Experimental
    Emerging Field-expedient Care

    Emerging Field-expedient Care Group will receive a combination of emerging nonvaginal interventions aimed at normalizing sensory, motor, and autonomic nervous system dysfunction including pain neuroscience education, diaphragmatic breathing training, and lumbopelvic manual therapy and dry needing treatment

    Other: Pain Neuroscience Education · Other: Lumbopelvic and Hip Therapeutic Exercise · Other: Extrapelvic Manual Therapy · Other: Extrapelvic Dry Needling · Other: Deep Paced Diaphragmatic Breathing Training · Other: Chronic Pelvic Pain Education

  • Active comparator
    Gold-standard Intravaginal Specialist Care

    Gold-standard Intravaginal Specialist Care Group will receive tailored intravaginal and intrarectal manual therapy and biofeedback intervention by a pelvic-health specialist.

    Other: Pain Neuroscience Education · Other: Lumbopelvic and Hip Therapeutic Exercise · Other: Deep Paced Diaphragmatic Breathing Training · Other: Chronic Pelvic Pain Education · Other: Intravaginal and intrarectal pelvic floor physical therapy

Interventions

  • OtherPain Neuroscience Education

    Participants will watch and discuss a short (5-minute) standardized pain neuroscience education video with their treating provider. The video explains and illustrates how chronic pain is different than acute pain in that it concerns nervous system hypersensitivity more than local tissue damage. Pain neuroscience education principles from the video will then be used to throughout all interventions to coach the participants through graded exposure of activities that may have previously been painful or provoked anxiety.

  • OtherLumbopelvic and Hip Therapeutic Exercise

    These motor control exercises will focus on proprioception, coordination, and sensorimotor control training and include progressive exercises that focus on transversus abdominis, lumbar multifidus, diaphragmatic, pelvic floor muscles, and deep hip stabilizers. Exercises will progress from more stabilized (e.g., pelvic tilt, cat and cow) to less stabilized and more dynamic and functional (e.g., forward bending, eccentric squat) to mimic the demands of work duty. Exercise will be trained and progressed during the clinical visits and be performed daily at home.

  • OtherExtrapelvic Manual Therapy

    Thrust and non-thrust manual therapy will be applied to the lumbar facet, sacroiliac, and hip joints based upon the clinical exam in a semi-standardized manner

  • OtherExtrapelvic Dry Needling

    Dry needling treatment to muscles of the lumbopelvic and upper thigh regions in a semi-standardized manner based upon a palpatory examination. The palpatory examination will include the erector spinae, lumbar multifidi, gluteus medius/minimus, piriformis, illiacus, and hip adductor muscles.

  • OtherDeep Paced Diaphragmatic Breathing Training

    The breathing intervention will start with education describing the link between the diaphragm and the pelvic floor to include awareness of any breath holding patterns and finding positions that facilitate expansion of the ribs, abdominals, and pelvic floor muscles with inhalation. Then progressive training will be given to encourage deep breathing at a pace of approximately 6 breaths per minute.

  • OtherChronic Pelvic Pain Education

    During the first visit, participants will receive and briefly discuss the 2023 standardized patient educational handout created by the International Pelvic Pain Society with their treating provider. The educational handout describes chronic pelvic pain etiology, typical symptoms, examination, and treatments.

  • OtherIntravaginal and intrarectal pelvic floor physical therapy

    Superficial vulvar, perineal and intravaginal manual therapy and biofeedback utilizing commonly used techniques in previous research selected based on identified impairments from the pelvic floor examination will be performed.

06

What researchers measure

Primary outcomes

  1. The Pelvic Floor Distress Inventory (PFDI-20)

    The Pelvic Floor Distress Inventory (PFDI-20) is a 20-item questionnaire that assesses the frequency and severity of pelvic floor symptoms. It consists of 3 subscales: the pelvic floor distress inventory 6 (POPDI-6), the colorectal anal distress inventory 8 (CRADI-8), and the urinary distress inventory 6 (UDI-6). Each question is rated on a scale of 0-4 with 0 representing "no symptoms," and 4 representing "quite a bit." Higher scores represent more bothersome symptoms.

    Time frame: 1 week and 1, 3, 6, and 12 months

  2. The Genitourinary Pain Index (GUPI)

    The Genitourinary Pain Index (GUPI) is 9-item questionnaire that assesses presence, location, frequency, quality and quantity of genitourinary pain in both men and women.

    Time frame: 1 week and 1, 3, 6, and 12 months

Secondary outcomes

  1. Numeric pain rating scale (NPRS)

    Participants will rate their current pain on a scale of 0-10 with zero being no pain at all and 10 being the worst pain imaginable. Subjects will also rate their worst pain within the past week and their pain at its best within the last week, to gain an assessment of variability and intensity of pain.

    Time frame: 1 week and 1, 3, 6, and 12 months

  2. Pelvic Floor Muscle Tone

    On a subset of 150 participants, pelvic floor muscle tone will be estimated from shear wave elastography ultrasound (US).

    Time frame: 1 week and 1, 3, 6, and 12 months

  3. Superficial Lumbopelvic Muscle Tone

    On a subset of 150 participants, resting tone of several lumbopelvic muscles will be measures using a MyotonPRO device.

    Time frame: 1 week and 1, 3, 6, and 12 months

  4. Pelvic Floor Pain Sensitivity

    On a subset of 150 participants, pelvic floor pain sensitivity will be assessed using pain algometry.

    Time frame: 1 week and 1, 3, 6, and 12 months

  5. Lumbopelvic Muscle Pain Sensitivity

    On a subset of 150 participants, Pain sensitivity of the same lumbopelvic muscles and locations assessed using the MyotonPRO will be measured using a digital hand-held pressure algometer.

    Time frame: 1 week and 1, 3, 6, and 12 months

07

Study locations

2 sites
  • U.S. Army Medical Center of Excellence (MEDCoE)
    San Antonio, Texas 78234, United States
  • Baylor University
    Waco, Texas 76701, United States
08

References and documents

Individual participant data

Plan to share: No — Depending upon where the findings of this study are published, sharing individual participant data might not be feasible.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 20, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06697548
Lead sponsor
Baylor University
Collaborators
Congressionally Directed Medical Research Programs
Responsible party
Sponsor
First posted
Nov 20, 2024
Start date
Jan 2025 (estimated)
Primary completion
Jun 2028 (estimated)
Completion
Jun 2028 (estimated)
Last update
Nov 20, 2024

Study contacts

Shane Koppenhaver, PhD
Contact
shane_koppenhaver@baylor.edu
210-722-3671
Laurel Proulx, PhD
Contact
laurel_proulx@baylor.edu
816-699-5007‬

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion